Literature DB >> 17695727

Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage.

Kiyotsugu Yoshida1.   

Abstract

Abl is a ubiquitously expressed nonreceptor tyrosine kinase that is involved in diverse cellular signaling cascades. The cellular response mediated by Abl depends upon its subcellular localization. Expression of Abl in the cytoplasm results in cell proliferation and survival. In contrast, nuclear Abl is activated and induces apoptosis after genotoxic stress. Recent studies have demonstrated the molecular mechanisms by which c-Abl moves into the nucleus in the response to DNA damage. In normal cells, 14-3-3 proteins sequester c-Abl in the cytosol. Upon exposure of cells to genotoxic agents, c-jun N-terminal kinase is activated and phosphorylates 14-3-3, resulting in the release of c-Abl into the nucleus. Moreover, nuclear targeting of c-Abl is required for the induction of apoptosis in response to DNA-damaging agents. Thus, c-Abl may determine cell fate via its subcellular localization. This review summarizes the implications of these findings on our understanding of Abl-regulated cellular functions and potential therapeutic strategies to modulate the aberrant kinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695727     DOI: 10.1007/978-0-387-69116-9_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse.

Authors:  Yanping Huang; Erin O Comiskey; Renell S Dupree; Shuixing Li; Anthony J Koleske; Janis K Burkhardt
Journal:  Blood       Date:  2008-02-27       Impact factor: 22.113

2.  Proteomics and pathway analysis identifies JNK signaling as critical for high linear energy transfer radiation-induced apoptosis in non-small lung cancer cells.

Authors:  Sara Ståhl; Eva Fung; Christopher Adams; Johan Lengqvist; Birgitta Mörk; Bo Stenerlöw; Rolf Lewensohn; Janne Lehtiö; Roman Zubarev; Kristina Viktorsson
Journal:  Mol Cell Proteomics       Date:  2009-01-23       Impact factor: 5.911

3.  Doxorubicin bypasses the cytoprotective effects of eIF2α phosphorylation and promotes PKR-mediated cell death.

Authors:  P Peidis; A I Papadakis; H Muaddi; S Richard; A E Koromilas
Journal:  Cell Death Differ       Date:  2010-06-18       Impact factor: 15.828

4.  Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.

Authors:  C Walz; N C P Cross; R A Van Etten; A Reiter
Journal:  Leukemia       Date:  2008-06-05       Impact factor: 11.528

5.  Regulation of neuronal cell death by c-Abl-Hippo/MST2 signaling pathway.

Authors:  Weizhe Liu; Junbing Wu; Lei Xiao; Yujie Bai; Aiqin Qu; Zheng Zheng; Zengqiang Yuan
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

6.  c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.

Authors:  Anne-Laure Mahul-Mellier; Bruno Fauvet; Amanda Gysbers; Igor Dikiy; Abid Oueslati; Sandrine Georgeon; Allan J Lamontanara; Alejandro Bisquertt; David Eliezer; Eliezer Masliah; Glenda Halliday; Oliver Hantschel; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-01-09       Impact factor: 5.121

7.  Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?

Authors:  Harm Jan Bogaard; Jurjan Aman
Journal:  Am J Respir Cell Mol Biol       Date:  2022-08       Impact factor: 7.748

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.